The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) is interested in how social media affects the public’s perception of drugs.
https://www.pharmalive.com/wp-content/uploads/2020/02/FDA-Social-Media-BioSpace-2-18-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-02-18 01:27:252020-02-21 13:07:59FDA to Study Instagram and Social Media Influencers